Susan Shapiro
Overview
Explore the profile of Susan Shapiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
454
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shapiro S, Majert J, Obeidalla A, Clift A, Havord S, Jebamani A, et al.
J Thromb Haemost
. 2025 Jan;
23(1):97-107.
PMID: 39798971
Background: Same-day emergency care (SDEC) is an expanding area of hospital acute medical care. It aims to minimize delays and manage medical emergency patients within the same day, enabling hospitalization...
2.
Chowdary P, Duran B, Batty P, Lowe G, Jones A, Pollard D, et al.
Haemophilia
. 2024 Nov;
31(1):26-38.
PMID: 39565651
Introduction: 2022 was a landmark year with two adeno-associated viral vectors (AAVs) receiving conditional marketing authorization from EMA for the treatment of persons with severe haemophilia A and severe to...
3.
Madan B, Ozelo M, Raheja P, Symington E, Quon D, Leavitt A, et al.
J Thromb Haemost
. 2024 Apr;
22(7):1880-1893.
PMID: 38614387
Background: Valoctocogene roxaparvovec transfers a human factor (F)VIII coding sequence into hepatocytes of people with severe hemophilia A to provide bleeding protection. Objectives: To present 3-year efficacy and safety in...
4.
Mitchell J, Khan D, Rana R, Kriek N, Unsworth A, Sage T, et al.
Platelets
. 2023 Oct;
34(1):2264940.
PMID: 37822056
Multiple myeloma (MM) and its precursor states, smoldering myeloma (SM) and monoclonal gammopathy of undetermined significance (MGUS) are associated with increased incidence of thrombosis, however the cause of this is...
5.
Mitchell J, Little G, Bye A, Gaspar R, Unsworth A, Kriek N, et al.
Res Pract Thromb Haemost
. 2023 Aug;
7(5):100200.
PMID: 37601014
Background: Factor XIII (FXIII) is an important proenzyme in the hemostatic system. The plasma-derived enzyme activated FXIII cross-links fibrin fibers within thrombi to increase their mechanical strength and cross-links fibrin...
6.
Sangha G, Obeidalla A, Taylor S, McKeown W, Shapiro S
Haemophilia
. 2023 Aug;
29(5):1371-1375.
PMID: 37556315
No abstract available.
7.
Funding E, Lowe G, Poulsen L, Shapiro S, Oldenburg J, Eriksson D, et al.
Adv Ther
. 2023 Jun;
40(9):3770-3783.
PMID: 37351812
Introduction: The current study describes real-world clinical outcomes and factor usage among patients with haemophilia B switching from standard half-life factor IX (SHL FIX) treatment to recombinant factor IX Fc...
8.
Ejaz A, ODoherty C, Sharpley F, Curry N, Shapiro S, Desborough M
Obstet Med
. 2023 May;
16(1):56-58.
PMID: 37139513
Pregnancy-associated haemophilia A is an uncommon, acquired bleeding disorder which usually presents post-partum; very rarely it may present during pregnancy. No consensus guidelines exist on the management of this condition...
9.
Tseng C, Roddick A, Bottomley M, Shapiro S, Udayaraj U
EJHaem
. 2023 Feb;
4(1):291-293.
PMID: 36819183
No abstract available.
10.
Mahlangu J, Kaczmarek R, von Drygalski A, Shapiro S, Chou S, Ozelo M, et al.
N Engl J Med
. 2023 Feb;
388(8):694-705.
PMID: 36812433
Background: Valoctocogene roxaparvovec delivers a B-domain-deleted factor VIII coding sequence with an adeno-associated virus vector to prevent bleeding in persons with severe hemophilia A. The findings of a phase 3...